Spontaneous and Prostatic Steroid Binding Protein Peptide-Induced Autoimmune Prostatitis in the Nonobese Diabetic Mouse1

Chronic nonbacterial prostatitis is a poorly defined syndrome of putative autoimmune origin. To further understand its pathogenesis, we have analyzed autoimmune prostatitis in the NOD mouse, a strain genetically prone to develop different organ-specific autoimmune diseases. Spontaneous development of autoimmune prostatitis in the NOD male, defined by lymphomonuclear cell infiltration in the prostate gland, is well-established by ∼20 wk of age and is stably maintained afterward. Disease development is indistinguishable in NOD and NOR mice, but is markedly delayed in IFN-γ-deficient NOD mice. A T cell response to the prostate-specific autoantigen prostatic steroid-binding protein (PSBP) can be detected in NOD males before development of prostate infiltration, indicating lack of tolerance to this self Ag. The intraprostatic inflammatory infiltrate is characterized by Th1-type CD4+ T cells, which are able to transfer autoimmune prostatitis into NOD.SCID recipients. We characterize here experimental autoimmune prostatitis, detected by intraprostatic infiltrate and PSBP-specific T cell responses, induced in 6- to 8-wk-old NOD males by immunization with synthetic peptides corresponding to the C1 subunit of PSBP. Three PSBP peptides induce in NOD mice vigorous T and B cell responses, paralleled by a marked lymphomononuclear cell infiltration in the prostate. Two of these peptides, PSBP21–40 and PSBP61–80, correspond to immunodominant self epitopes naturally processed in NOD mice after immunization with PSBP, whereas peptide PSBP91–111 represents a cryptic epitope. These model systems address pathogenetic mechanisms in autoimmune prostatitis and will facilitate testing and mechanistic analysis of therapeutic approaches in this condition.

[1]  S. Senju,et al.  Identification of naturally processed helper T-cell epitopes from prostate-specific membrane antigen using peptide-based in vitro stimulation. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  H. Kikutani,et al.  The murine autoimmune diabetes model: NOD and related strains. , 1992, Advances in immunology.

[3]  R. Henderson,et al.  Identification of Naturally Processed CD4 T Cell Epitopes from the Prostate-Specific Antigen Kallikrein 4 Using Peptide-Based In Vitro Stimulation1 , 2002, The Journal of Immunology.

[4]  Maccioni,et al.  Prostatein (or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis , 1998, Clinical and experimental immunology.

[5]  Zhen Xiao,et al.  Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  N. Ilhan,et al.  Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome , 2001, International journal of urology : official journal of the Japanese Urological Association.

[7]  R. Alexander,et al.  Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. , 1997, Urology.

[8]  A. Miller,et al.  Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.

[9]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.

[10]  P. Yarnold,et al.  IL-1β AND TNF-α IN PROSTATIC SECRETIONS ARE INDICATORS IN THE EVALUATION OF MEN WITH CHRONIC PROSTATITIS , 2000 .

[11]  Bhagirath Singh,et al.  The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. , 1997, Immunity.

[12]  L. True,et al.  Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy. , 1997, Journal of immunology.

[13]  A. Shafik Re: Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort study. , 2002, The Journal of urology.

[14]  Vladimir Brusic,et al.  A Peptide-binding Motif for I-Ag7, the Class II Major Histocompatibility Complex (MHC) Molecule of NOD and Biozzi AB/H Mice , 1997, The Journal of experimental medicine.

[15]  A. Doble,et al.  Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS) , 2002, Clinical and experimental immunology.

[16]  D. McNeel,et al.  Identification of Antigen-Specific IgG in Sera from Patients with Chronic Prostatitis , 2004, Journal of Clinical Immunology.

[17]  Y. Nishizuka,et al.  Experimental autoimmune prostatitis after neonatal thymectomy in the mouse. , 1985, Clinical and experimental immunology.

[18]  M. Depiante-Depaoli,et al.  Experimental Autoimmune Damage to Rat Male Accessory Glands (MAG) * , 1981 .

[19]  M. Resnick,et al.  Experimental rodent models of prostatitis: limitations and potential , 2007, Prostate Cancer and Prostatic Diseases.

[20]  P. Ohashi,et al.  Making and breaking tolerance. , 2002, Current opinion in immunology.

[21]  A. Isacchi,et al.  Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes , 2000, The Journal of Immunology.

[22]  M. Pontari,et al.  Theories of prostatitis etiology , 2002, Current Urology Reports.

[23]  K. Itoh,et al.  Identification of Peptide Vaccine Candidates for Prostate Cancer Patients with HLA-A3 Supertype Alleles , 2005, Clinical Cancer Research.

[24]  J. Cabaniols,et al.  Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Gustafsson,et al.  Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Takeuchi,et al.  Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. , 1994, Immunology.

[27]  J. Krieger,et al.  NIH consensus definition and classification of prostatitis. , 1999, JAMA.

[28]  M. Pontari,et al.  Mechanisms in prostatitis/chronic pelvic pain syndrome. , 2008, The Journal of urology.

[29]  M. Parker,et al.  Organization and Expression of Genes Encoding Prostatic Steroid Binding Protein , 1984, Annals of the New York Academy of Sciences.

[30]  R. Alexander,et al.  Identification of HLA-DRB1*1501–Restricted T-cell Epitopes from Prostate-Specific Antigen , 2005, Clinical Cancer Research.

[31]  R. Shattock,et al.  Interleukin‐8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis , 2006, BJU international.

[32]  A. Schaeffer,et al.  Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. , 2000, Urology.

[33]  A. Reiss,et al.  Syndrome , 1990, Biological Psychiatry.

[34]  M. Carini,et al.  Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. , 2007, European urology.

[35]  W. Frankel,et al.  NOR/Lt Mice: MHC-Matched Diabetes-Resistant Control Strain for NOD Mice , 1992, Diabetes.

[36]  M. Barry,et al.  How common is prostatitis? A national survey of physician visits. , 1998, The Journal of urology.

[37]  P. Humphrey,et al.  Development of a mouse model for nonbacterial prostatitis. , 1994, The Journal of urology.

[38]  Lawrence Steinman,et al.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[39]  L. Adorini,et al.  Understanding autoimmune diabetes: insights from mouse models. , 2002, Trends in molecular medicine.

[40]  E. Sercarz,et al.  Understanding crypticity is the key to revealing the pathogenesis of autoimmunity. , 2005, Trends in immunology.

[41]  R. Berger Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. , 2005, The Journal of urology.

[42]  V. Rivero,et al.  Prostatein or steroid binding protein (PSBP) induces experimental autoimmune prostatitis (EAP) in NOD mice. , 2002, Clinical immunology.

[43]  J. Hebel,et al.  Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. , 1998, Urology.

[44]  M. Pontari,et al.  Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. , 2002, The Journal of urology.

[45]  V. Rivero,et al.  Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. , 2005, Clinical immunology.

[46]  L. Adorini,et al.  IL-12 Administration Accelerates Autoimmune Diabetes in Both Wild-Type and IFN-γ-Deficient Nonobese Diabetic Mice, Revealing Pathogenic and Protective Effects of IL-12-Induced IFN-γ1 , 2003, The Journal of Immunology.

[47]  J. Krieger,et al.  Epidemiology of prostatitis: new evidence for a world-wide problem , 2003, World Journal of Urology.

[48]  V. Rivero,et al.  Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). , 1998, Journal of autoimmunity.

[49]  Corman.,et al.  Recognition of prostate‐specific antigenic peptide determinants by human CD4 and CD8 T cells , 1998, Clinical and experimental immunology.

[50]  A. Tolcher,et al.  Management of high risk metastatic prostate cancer: the case for novel therapies. , 2006, The Journal of urology.

[51]  Y. Nishizuka,et al.  Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance , 1987, The Journal of experimental medicine.

[52]  D. McNeel,et al.  Identification of T helper epitopes from prostatic acid phosphatase. , 2001, Cancer research.

[53]  M. Depiante-Depaoli,et al.  Experimental Autoimmune Damage to Rat Male Accessory Glands. II. T Cell Requirement in Adoptive Transfer of Specific Tissue Damage , 1984, American journal of reproductive immunology : AJRI : official journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction.

[54]  M. Depiante-Depaoli,et al.  Experimental autoimmunity to rat male accessory glands (MAG): circulating antibodies, immunoglobulins bound to target glands, and immunoglobulins-secreting cells. , 1985, American journal of reproductive immunology and microbiology : AJRIM.

[55]  C. Doglioni,et al.  Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol1 , 2006, The Journal of Immunology.

[56]  R. Alexander,et al.  PSA is a candidate self‐antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome , 2000, The Prostate.

[57]  M. Depiante-Depaoli,et al.  Experimental Autoimmune Damage to Rat Male Accessory Glands. I. Transfer of Autoimmune Response by Spleen Cells , 1984, American journal of reproductive immunology : AJRI : official journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction.